Literature DB >> 32995898

[The microbiome in head and neck tumors-initial findings and outlook].

S Lang1, S Brandau2, J R Marchesi3, J Jablonska2, D Thurnher4, S Mattheis2, J Buer5, T Hussain2.   

Abstract

Technical progress in molecular biology has allowed for a more detailed analysis of the composition of the human microbiome in recent years. Inter- and intraindividual differences in microbiome composition have been demonstrated, which in part correlate with the occurrence of certain diseases. For some of the so-called oncomicrobes, a direct relationship between their effect on the host organism and carcinogenesis has been demonstrated, predominantly for gastrointestinal cancers. Initial results for head and neck cancer show inter- and intraindividual differences in the local microbiota of the tumor environment, with certain bacterial strains over- or underrepresented. Our results confirm these findings, e.g., by showing a relative abundance of fusobacteria in tumor tissue while streptococci were relatively reduced. Currently available results show a high degree of inter- and intraindividual variation, thus requiring larger patient cohorts for functional analyses.

Entities:  

Keywords:  Head and neck neoplasms; Host microbial interactions; Immunotherapy; Microbiome; Microbiota

Mesh:

Year:  2020        PMID: 32995898     DOI: 10.1007/s00106-020-00950-w

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  2 in total

1.  Streptococcus cristatus modulates the Fusobacterium nucleatum-induced epithelial interleukin-8 response through the nuclear factor-kappa B pathway.

Authors:  G Zhang; R Chen; J D Rudney
Journal:  J Periodontal Res       Date:  2011-04-26       Impact factor: 4.419

2.  16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment.

Authors:  Rafael Guerrero-Preston; Filipa Godoy-Vitorino; Anne Jedlicka; Arnold Rodríguez-Hilario; Herminio González; Jessica Bondy; Fahcina Lawson; Oluwasina Folawiyo; Christina Michailidi; Amanda Dziedzic; Rajagowthamee Thangavel; Tal Hadar; Maartje G Noordhuis; William Westra; Wayne Koch; David Sidransky
Journal:  Oncotarget       Date:  2016-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.